The 2020 AHA/ACC guidelines recommend periodic 24-48-hour ambulatory electrocardiogram monitoring to screen for atrial and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
The paper highlights the importance of periodic 24-48-hour ambulatory ECG monitoring for arrhythmia risk stratification in patients with hypertrophic cardiomyopathy based on 2020 AHA/ACC guidelines.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy, presenting significant clinical heterogeneity. Arrhythmia risk stratification and detection are critical components in the evaluation and management of all cases of HCM. The 2020 American Heart Association/American College of Cardiology HCM guidelines provide new recommendations for periodic 24-48-hour ambulatory electrocardiogram monitoring to screen for atrial and ventricular arrhythmias. A strategy of more frequent or prolonged monitoring would lead to earlier arrhythmia recognition and the potential for RSUM La cardiomyopathie hypertrophique (CMH) qui est la cardiomyopathie h er editaire la plus fr equente pr esente une h et erog en eit e clinique importante. La stratification du risque d'arythmies et leur d etection sont des composantes essentielles de l' evaluation et de la prise en charge de tous les cas de CMH. Les lignes directrices 2020 de l'American Heart Association et de l'American College of Cardiology en matire de CMH fournissent les nouvelles recommandations sur la surveillance p eriodique de l' electrocardiogramme ambulatoire de 24-48 heures pour d epister les arythmies auriculaires et ventriculaires.
Du et al. (Thu,) conducted a review in Hypertrophic cardiomyopathy (HCM). Ambulatory electrocardiogram monitoring was evaluated. The 2020 AHA/ACC guidelines recommend periodic 24-48-hour ambulatory electrocardiogram monitoring to screen for atrial and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.